FRNM
Freenome, Inc. Common stock
Nasdaq · usd
Freenome, Inc. Common stock (FRNM) trades at $12.58 (-1.49%) as of 3:19:47 PM EDT on Oct 26, 2026, -21.20% over the past month. Market cap is $1.37B, with 3.3 days to cover in short interest.
Stock performance
How Freenome, Inc. Common stock (FRNM) stock has performed from one day to one year, with its 52-week range.
- 1D
- -1.33%
- 1W
- +0.24%
- 1M
- -21.20%
- YTD
- -3.15%
- 1Y
- -3.15%
- 52-wk range
- $9.97 – $17.50
Key statistics
Today's trading snapshot for FRNM: day range, open, previous close, volume and market cap.
- Day range
- $12.50 – $13.11
- Open
- $13.10
- Prev close
- $12.77
- Volume
- 249.88K
- Market cap
- $1.37B
- Shares out
- 107.45M
8-K filings
Material corporate events Freenome, Inc. Common stock has disclosed to the SEC on Form 8-K.
- Clinical trial resultsOct 20, 2026
In the Company's PREEMPT CRC study, which enrolled more than 48,000 participants, the test demonstrated 81% sensitivity for CRC, 90% specificity for advanced colorectal neoplasia, and a 99.9% NPV in an analysis adjusted to the 2020 U.S. Census age and sex distribution.
- Partnership or collaborationJul 27, 2026
Under the terms of the commercial agreement signed between Freenome and Abbott in August 2025, Freenome will receive a $100 million milestone payment from Abbott for this FDA approval. Abbott will exclusively commercialize SimpleScreen CRC in the U.S., building on the provider relationships, reimbursement expertise and patient support programs it has developed through Cologuard®.
- Private placementJul 24, 2026
The PIPE Investors also have demand registration rights pursuant to the terms of the Subscription Agreements... New Freenome issued certain securities described in the Introductory Note under Section 4(a)(2) of the Securities Act, in transactions by an issuer not involving a public offering.
FRNM short interest
How heavily FRNM is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 3.3
- Short interest
- 3.4M
- Avg volume
- 1.04M
As of · reported to FINRA twice monthly.
FRNM news
The latest news and headlines about Freenome, Inc. Common stock (FRNM).
- Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026positiveGlobeNewswire Inc.· Oct 11, 2026
Frequently asked questions
What is the Freenome, Inc. Common stock (FRNM) stock price today?
Freenome, Inc. Common stock (FRNM) is trading at $12.58 (-1.49% on the day) as of 3:19:47 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Freenome, Inc. Common stock?
Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection.
What is the short interest in FRNM?
As of Sep 30, 2026, FRNM has 3.4M shares short and 3.3 days to cover.
What exchange is FRNM listed on?
Freenome, Inc. Common stock (FRNM) trades on Nasdaq in USD, in the SERVICES-MEDICAL LABORATORIES industry.
Build with AI
Build an analysis of FRNM with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a FRNM analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.